Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiang-Fan Chen

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Physiology|July 9, 2024
Volitional modulation of neuronal activity in the external globus pallidus by engagement of the cortical-basal ganglia circuitShengtao Luo, Xiaopeng Zhou, Hui Zhou, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's diseaseJacobus P Petzer, Neal Castagnoli, Michael A Schwarzschild, et al.
Journal of Neurosurgery|February 10, 2009
The role of adenosine in hypercarbic hyperemia: in vivo and in vitro studies in adenosine 2(A) receptor knockout and wild-type miceGrzegorz Miekisiak, Kristen Yoo, Adam L Sandler, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 27, 2006
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitisH Thomas Lee, Mihwa Kim, Jin Deok Joo, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2025
Therapeutic potential of 40 Hz flickering light stimulation in Alzheimer's disease: Mechanisms, evidence, and controversiesXuan-Yue Wang, Yu-Juan Jia, Jianxiong Zhang, et al.
Neurology|December 10, 2003
Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's diseaseJiang-Fan Chen, Silva Fredduzzi, Elena Bastia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 28, 2007
Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritisGabriela E Garcia, Luan D Truong, Ping Li, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|June 23, 2011
Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learningCatherine J Wei, Philipp Singer, Joana Coelho, et al.
The Journal of Physiology|December 19, 2022
Neural representation and modulation of volitional motivation in response to escalating effortsLiping Zhang, Chengwei Liu, Xiaopeng Zhou, et al.
Neurology|December 10, 2003
Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's diseaseMichael A Schwarzschild, Kui Xu, Emin Oztas, et al.
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Physiology|July 9, 2024
Volitional modulation of neuronal activity in the external globus pallidus by engagement of the cortical-basal ganglia circuitShengtao Luo, Xiaopeng Zhou, Hui Zhou, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 27, 2008
Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's diseaseJacobus P Petzer, Neal Castagnoli, Michael A Schwarzschild, et al.
Journal of Neurosurgery|February 10, 2009
The role of adenosine in hypercarbic hyperemia: in vivo and in vitro studies in adenosine 2(A) receptor knockout and wild-type miceGrzegorz Miekisiak, Kristen Yoo, Adam L Sandler, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 27, 2006
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitisH Thomas Lee, Mihwa Kim, Jin Deok Joo, et al.
Journal of Alzheimer'S Disease : JAD|October 22, 2025
Therapeutic potential of 40 Hz flickering light stimulation in Alzheimer's disease: Mechanisms, evidence, and controversiesXuan-Yue Wang, Yu-Juan Jia, Jianxiong Zhang, et al.
Neurology|December 10, 2003
Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's diseaseJiang-Fan Chen, Silva Fredduzzi, Elena Bastia, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 28, 2007
Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritisGabriela E Garcia, Luan D Truong, Ping Li, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|June 23, 2011
Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learningCatherine J Wei, Philipp Singer, Joana Coelho, et al.
The Journal of Physiology|December 19, 2022
Neural representation and modulation of volitional motivation in response to escalating effortsLiping Zhang, Chengwei Liu, Xiaopeng Zhou, et al.
Neurology|December 10, 2003
Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's diseaseMichael A Schwarzschild, Kui Xu, Emin Oztas, et al.
Pageof 22